C3309C STMicroelectronics Reports Q4 and FY 2024 Financial ResultsQ4 net revenues $3.32 billion; gross margin 37.7%; operating margin ...
(GLOBE NEWSWIRE) -- 89bio, Inc. ("89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver ...
Goldman Sachs & Co. LLC, Leerink Partners and BofA Securities are acting as lead book-running managers and Cantor is acting ...
Frank Possemato, adjunct faculty in the English department, is self-publishing a new workbook on Amazon that offers an ...